You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

Ironshore Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for IRONSHORE PHARMS, and what generic alternatives to IRONSHORE PHARMS drugs are available?

IRONSHORE PHARMS has one approved drug.

There are sixteen US patents protecting IRONSHORE PHARMS drugs.

There are thirty-four patent family members on IRONSHORE PHARMS drugs in fourteen countries.

Summary for Ironshore Pharms

International Patents:	34
US Patents:	16
Tradenames:	1
Ingredients:	1
NDAs:	1

Drugs and US Patents for Ironshore Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ironshore Pharms	JORNAY PM	methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	209311-001	Aug 8, 2018		RX	Yes	No	11,911,518	⤷ Subscribe				⤷ Subscribe
Ironshore Pharms	JORNAY PM	methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	209311-001	Aug 8, 2018		RX	Yes	No	11,241,391	⤷ Subscribe				⤷ Subscribe
Ironshore Pharms	JORNAY PM	methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	209311-001	Aug 8, 2018		RX	Yes	No	10,881,618	⤷ Subscribe				⤷ Subscribe
Ironshore Pharms	JORNAY PM	methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	209311-004	Aug 8, 2018		RX	Yes	No	10,292,937	⤷ Subscribe				⤷ Subscribe
Ironshore Pharms	JORNAY PM	methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	209311-001	Aug 8, 2018		RX	Yes	No	9,034,902	⤷ Subscribe				⤷ Subscribe
Ironshore Pharms	JORNAY PM	methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	209311-003	Aug 8, 2018		RX	Yes	No	10,617,651	⤷ Subscribe				⤷ Subscribe
Ironshore Pharms	JORNAY PM	methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	209311-001	Aug 8, 2018		RX	Yes	No	11,241,392	⤷ Subscribe	Y			⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for Ironshore Pharms Drugs

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration
Canada	2830788	⤷ Subscribe
Brazil	112013024401	⤷ Subscribe
South Korea	20160135373	⤷ Subscribe
China	103608004	⤷ Subscribe
Japan	2014508812	⤷ Subscribe
Japan	2022066315	⤷ Subscribe
Japan	6043785	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.